Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Takkt AG

Start price
Target price
Perf. (%)
€15.72
19.04.22
€17.00
19.04.23
-0.76%
02.05.22

Standard Investments for future growth
Differentiated customer and product portfolio
Top 10 in its market
Higher risks for its business
GCP Applied Technologies Inc

Start price
Target price
Perf. (%)
€28.80
19.04.22
€25.00
19.04.23
14.58%
20.04.23

Probably not worthwhile Investment
buy
Curis Inc.

Start price
Target price
Perf. (%)
€1.14
19.04.22
-
19.04.23
-21.19%
01.05.22

Risky Investment
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€5.99
19.04.22
-
12.04.24
-68.19%
12.04.24

Could be worthwhile Investment >10% per year
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€3.20
19.04.22
-
12.04.26
-88.73%
16.02.24

Could be worthwhile Investment >10% per year
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€3.20
18.04.22
-
18.04.23
-10.28%
30.04.22

Could be very worthwhile Investment >20% year
buy
Allkem Ltd.

Start price
Target price
Perf. (%)
€9.20
18.04.22
€12.00
18.04.23
-12.18%
30.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Overstock.com

Start price
Target price
Perf. (%)
€35.46
17.04.22
-
17.04.23
-10.60%
30.04.22

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
Commtouch Software

Start price
Target price
Perf. (%)
€2.58
17.04.22
-
17.04.23
-92.06%
18.04.23

Risky Investment
Homology Medicines Inc

Start price
Target price
Perf. (%)
€1.86
17.04.22
-
17.04.23
-49.96%
18.04.23

Probably not worthwhile Investment
buy
Tellurian Inc

Start price
Target price
Perf. (%)
€5.75
17.04.22
-
17.04.23
-70.84%
22.01.23

Probably not worthwhile Investment
Biofrontera AG ADR

Start price
Target price
Perf. (%)
€2.14
16.04.22
€1.00
16.04.23
-28.04%
30.04.22

Probably not worthwhile Investment
High valuation
negative Cash Flow expected
Increased challenges to pay loans and raise capital
Hexatronic Group AB

Start price
Target price
Perf. (%)
€8.55
16.04.22
€4.00
16.04.23
-10.10%
30.04.22

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Basware Oy

Start price
Target price
Perf. (%)
€39.75
16.04.22
€20.00
16.04.23
-1.51%
30.04.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Berentzen Gruppe AG

Start price
Target price
Perf. (%)
€6.76
16.04.22
-
16.04.23
-3.85%
30.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Future proof or reliable business model
buy
Verallia SA

Start price
Target price
Perf. (%)
€22.68
15.04.22
€28.00
15.04.23
64.81%
16.04.23

Could be worthwhile Investment >10% per year
buy
Carbios S.A.

Start price
Target price
Perf. (%)
€32.90
15.04.22
-
15.04.23
14.65%
02.02.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
buy
Nordex SE

Start price
Target price
Perf. (%)
€15.97
15.04.22
-
15.04.23
-44.68%
23.09.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
SMCP

Start price
Target price
Perf. (%)
€6.58
14.04.22
-
14.04.23
26.84%
15.04.23

Could be worthwhile Investment >10% per year
buy
Martin Midstream Partners L.P.

Start price
Target price
Perf. (%)
€1.02
13.04.22
€1.50
-
30.05.23

Could be worthwhile Investment >10% per year
Veru Inc

Start price
Target price
Perf. (%)
€9.33
13.04.22
€3.20
13.04.23
25.81%
18.04.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Inovio Pharma

Start price
Target price
Perf. (%)
€3.05
12.04.22
€1.60
12.04.23
-30.60%
03.08.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€2.35
12.04.22
€1.10
12.04.23
-25.72%
03.08.22

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€9.86
12.04.22
-
12.04.23
-0.02%
16.04.22

Could be worthwhile Investment >10% per year
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€21.85
12.04.22
-
12.04.23
-9.84%
12.04.23